K-RALA Capsules

Purchase K-RALA Capsules

GeroNova’s Stable, Low-Polymeric R-lipoic acid as Na-RALA) powder encapsulated and supplied under manufacturer's labeling. Finally, authentic product direct from the supplier. No more worries over authenticity and potency of bulk powders from unknown suppliers.

**PLEASE be aware and a careful shopper, this product is a full 100 mg active R-lipoic acid, not 70mg active RLA as some competitor products.** When comparing "apples to apples" cost per active mg per capsule, our 100mg is very cost competitive.

90 x 100mg vegcaps

This material is the stable salt form of R-Lipoic Acid. Researchers believe that R-lipoic acid may be up to 8 times more active than Alpha-Lipoic Acid.

Unstabilized RLA can contain harmful heavy metals and residual solvents that are very difficult to remove. Our processing of K-RALA removes all traces of residual solvents from the raw material.

This form of r-lipoic acid (Na-RALA, Sodium RLA) does NOT offer the natural sustained-release action of the MCT transported, liquicap, GeroNova products (R-PLUS, R-Plus CoQ10, Mito-GOLD).

Supplement Facts:

Serving Size: 1 Capsule.

Servings per container: 90
R-Lipoic Acid 100mg *
[derived from 145 mg Na-RALA]

*Daily value not established

Other Ingredients:
Cellulose, potassium bicarbonate, sodium bicarbonate.

Product notes: This product contains no animal products and is 100% vegan. No yeast, wheat, corn, milk, soy, glutens, sugar or animal products.

Directions: Take 2-3 capsules daily or as recommended by your health care provider.

Requires no refrigeration and does not polymerize, whereas unstabilized RLA polymerizes at temperatures slightly above ambient. The polymerization of RLA is accelerated by light, heat and moisture.

BIOAVAILABILITY refers to the amount (or percent of dose) of RLA that reaches the systemic blood circulation and is therefore available for use by the cells. Bioavailability is dependent upon absorption. In pharmacology, the absolute bioavailability of RLA measures the availability of RLA in the systemic ciculation. This is determined by obtaining a blood plsama concentration over time, referred to as the AUC (area under the curve). Relative bioavailability compares the bioavailability of one product to another. In a preliminary human clinical trial, the AUC for GeroNova's Bio-Enhanced R-Lipioc Acid was 50 times higher than that of unstabilized RLA.

Purchase K-RALA Capsules